Heyman Richard A. reported option exercise involving 3,500 shares of Oric Pharmaceuticals, Inc. at $1.60 for $5.60k on Oct 1, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Director
DIR
Filed Oct 2, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$5,600Shares × reported price
Shares traded
3,500Common Stock
Price per share
$1.60Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
41,800Direct
Trade date
Oct 1, 2026Option exercise
Filed
Oct 2, 2026, 5:50 PM ET1-day reporting delay
Accession
0001584759-26-000017Code M · Transaction 235633
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Oct 1, 2026Sell3,500$12.91−$45,199.35Trade 235634
Oct 1, 2026Sell3,200$12.91−$41,325.12Trade 235635
Oct 1, 2026Option exercise3,500$0.00$0Trade 235636
4 transaction rows in this filing. Joint filers share the same rows.

ORIC price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ORIC · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +5.6%1w ago +7.9%1d ago +10%
Returns since7d −1.8%30d −24%90d180d1y

Footnotes in full

F1: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC. F2: This transaction was executed in multiple trades at prices ranging from $12.57 to $13.39. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F3: The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares. F4: The shares subject to the option are fully vested and immediately exercisable.